167 related articles for article (PubMed ID: 10397553)
21. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
[TBL] [Abstract][Full Text] [Related]
22. Antiretroviral rounds. When success is a pain.
Bartlett JG; del Rio C
AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
[No Abstract] [Full Text] [Related]
23. Drugs for HIV infection.
Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
[No Abstract] [Full Text] [Related]
24. Resolution of severe Kaposi's sarcoma after initiation of antiretroviral triple therapy.
Jung C; Bogner JR; Goebel F
Eur J Med Res; 1998 Sep; 3(9):439-42. PubMed ID: 9737891
[TBL] [Abstract][Full Text] [Related]
25. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
Moolasart P; Likanonsakul S
Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):280-7. PubMed ID: 12236426
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of nelfinavir in an HIV patient with renal insufficiency.
Izzedine H; Diquet B; Launay-Vacher V; Jouan M; Theou N; Deray G
AIDS; 1999 Oct; 13(14):1989. PubMed ID: 10513666
[No Abstract] [Full Text] [Related]
28. Management of HIV associated Kaposi's sarcoma in Malawi.
Mlombe Y
Malawi Med J; 2008 Dec; 20(4):129-32. PubMed ID: 19537395
[TBL] [Abstract][Full Text] [Related]
29. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.
Tanguilig GG; Rutzen AR; Ortega-Larrocea G
Am J Ophthalmol; 1998 Apr; 125(4):567-8. PubMed ID: 9559752
[No Abstract] [Full Text] [Related]
30. Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitor therapy.
Burdick AE; Carmichael C; Rady PL; Tyring SK; Badiavas E
J Am Acad Dermatol; 1997 Oct; 37(4):648-9. PubMed ID: 9344209
[No Abstract] [Full Text] [Related]
31. [Drug combination therapy for children infected with HIV/AIDS--own experience].
Prandota-Schoepp A; Klinowska-Skupniewska J
Przegl Epidemiol; 2001; 55 Suppl 3():135-41. PubMed ID: 11984940
[TBL] [Abstract][Full Text] [Related]
32. New developments in the etiopathogenesis and treatment of HIV-related Kaposi's sarcoma.
Whelan P; Scadden DT
Clin Dermatol; 2000; 18(4):469-77. PubMed ID: 11024314
[No Abstract] [Full Text] [Related]
33. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
De Luca A; Ammassari A; Cingolani A; Giancola ML; Antinori A
AIDS; 1998 Oct; 12(14):1937-8. PubMed ID: 9792402
[No Abstract] [Full Text] [Related]
34. The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
Fumagalli L; Zucchetti M; Parisi I; Viganò MG; Zecca B; Careddu A; D'Incalci M; Lazzarin A
Cancer Chemother Pharmacol; 2000; 45(6):495-501. PubMed ID: 10854138
[TBL] [Abstract][Full Text] [Related]
35. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F
HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164
[TBL] [Abstract][Full Text] [Related]
37. Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen.
Bani-Sadr F; Fournier S; Molina JM
AIDS; 2003 Jul; 17(10):1580-1. PubMed ID: 12824806
[No Abstract] [Full Text] [Related]
38. [Use of antiretroviral drugs in HIV infected children in a tropical area: a real benefit].
Timité-Konan AM; Fassinou P; Adonis-Koffy L; N'dja BB
Arch Pediatr; 2003 Sep; 10(9):831-2. PubMed ID: 12972212
[No Abstract] [Full Text] [Related]
39. Kaposi's sarcoma regression following treatment with a triple antiretroviral regimen containing nevirapine.
Shaw AJ; McLean KA
Int J STD AIDS; 1999 Jun; 10(6):417-8. PubMed ID: 10414887
[No Abstract] [Full Text] [Related]
40. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy.
Blum L; Pellet C; Agbalika F; Blanchard G; Morel P; Calvo F; Lebbé C
AIDS; 1997 Nov; 11(13):1653-5. PubMed ID: 9365774
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
